首页 | 本学科首页   官方微博 | 高级检索  
     

血清骨钙素水平与绝经后女性2型糖尿病患者骨密度的关系
引用本文:王筱婧,陈瑛,郁静嘉,焦培林,孙立昊,陶蓓,宣言,刘建民,王卫庆,赵红燕. 血清骨钙素水平与绝经后女性2型糖尿病患者骨密度的关系[J]. 诊断学理论与实践, 2014, 13(1): 68-71. DOI: 10.16150/j.1671-2870.a0376
作者姓名:王筱婧  陈瑛  郁静嘉  焦培林  孙立昊  陶蓓  宣言  刘建民  王卫庆  赵红燕
作者单位:上海交通大学医学院附属瑞金医院内分泌科上海市内分泌代谢病临床医学中心;
基金项目:国家自然科学基金(81170804)
摘    要:目的:探讨血清骨钙素水平与绝经后女性2型糖尿病(type 2 diabetes,T2DM)患者骨密度(bone minaral density,BMD)间的关系。方法:本研究为回顾性分析,共纳入505例绝经后女性,其中T2DM住院患者305例,非糖尿病对照者200例,采用双能X线骨密度仪(DXA)检测腰椎(第2至第4腰椎)、股骨颈和全髋的BMD,同时检测血清骨钙素(osteocalcin,OC)水平。结果:与正常对照组相比,T2DM组患者的血清OC水平显著降低(P<0.05),腰椎、股骨颈、全髋的BMD及体质量指数显著增高(P<0.01)均呈显著负相关;校正年龄、体质量指数和糖尿病病程后,血清OC水平与腰椎及全髋的BMD间仍存在明显的负相关。结论:血清OC水平与绝经后女性T2DM患者腰椎及全髋的BMD密切相关,随着OC水平的升高,BMD呈下降趋势,提示血清OC水平可作为早期筛查绝经后女性T2DM患者骨质疏松的生化指标,结合血清OC水平和BMD能更好地预测绝经后女性T2DM患者的骨质疏松和骨折的风险。

关 键 词:2型糖尿病  骨质疏松  骨密度  骨钙素  

Relationship between serum osteocalcin and bone mineral density in postmenopausal women with type 2 diabetes mellitus
WANG Xiaojing*,CHEN Ying',YU Jinjia,JIAO Peilin,SUN Lihao,TAO Bei,XUAN Yah,LIU Jianmin,WANG Weiqing,ZHAO Hongyan. Relationship between serum osteocalcin and bone mineral density in postmenopausal women with type 2 diabetes mellitus[J]. Journal of Diagnostics Concepts & Practice, 2014, 13(1): 68-71. DOI: 10.16150/j.1671-2870.a0376
Authors:WANG Xiaojing*  CHEN Ying'  YU Jinjia  JIAO Peilin  SUN Lihao  TAO Bei  XUAN Yah  LIU Jianmin  WANG Weiqing  ZHAO Hongyan
Affiliation:. Department of Endocrinology and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai 200025, China
Abstract:Objective: To investigate the relationship between serum level of osteocalcin (OC) and bone mineral density (BMD) in postmenopausal women with type 2 diabetes mellitus (T2DM). Methods: A total of 505 postmenopausal women aged (61±7)years were enrolled,including 305 subjects with T2DM and 200 without diabetes served as controls. Serum concentration of OC was determined, and BMDs at lumbar spine (L2-4), femoral neck (FN) and total hip (TH) were measured by dual-energy X-ray absorptiometry (DXA). Results: Serum levels of OC was lower(P〈0.05), whereas BMD (L24, FN,TH) and BMI were higher in T2DM patients than those in subjects without diabetes mellitus (P〈0.01). Linear correla- tion analysis showed that serum OC level was negatively correlated with L24BMD (r=-0.202, P〈0.05), TH BMD(r=-0.183, P〈0.05), and BMI (r=-0.289, P〈0.01) in postmenopausal women with T2DM. L2zBMD and TH BMD had a negative cor- relation with serum OC level even after adjustment for age, BMI and duration of diabetes. Conclusions: Serum OC level is closely related with L2~ and TH BMD in postmenopausal women with T2DM. BMD decreases with the increase of OC level, which demonstrates that serum OC could be used as a screening biochemical indicator for osteoporosis in post- menopausal women with T2DM. A combination of serum OC level and BMD might be a better predictor for osteoporosis and risk of fracture in postmenopausal women with T2DM than when assessed only by BMD.
Keywords:Type 2 diabetes  Osteoporosis  Bone mineral density  Osteocalcin
本文献已被 维普 等数据库收录!
点击此处可从《诊断学理论与实践》浏览原始摘要信息
点击此处可从《诊断学理论与实践》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号